Small Pharma Announces Significant Developments In Intellectual Property Portfolio
5 new patent grants with 3 expected upcoming patent grants in May.
Check out the latest company media, insights, and press releases. Delve into all the content on specific topic areas such as Company Financials.
5 new patent grants with 3 expected upcoming patent grants in May.
A highlight of recent news and events across April and May.
A highlight of recent news and events so far.
Patients who achieved remission within three months sustained remission to six months.
Statistically significant improvement in anxiety symptoms offers potential in indications beyond depression.
Dr. David Erritzoe shares his thoughts from a psychiatrist perspective.
Dr. Carol Routledge discusses our SPL028 Phase I healthy volunteer trial.
The Phase I study will compare IV and IM routes of SPL028 administration.
Two new patents approved for issue bringing total to 16 granted patents.
Dr. David Erritzoe shares what the results could mean for psychiatry.